Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Federico Alberici"'
Publikováno v:
Clinical Kidney Journal.
Primary membranous nephropathy (MN) is the most frequent cause of nephrotic syndrome in adults, due to a variety of autoantibodies, most frequently against phospholipase A2 receptor (PLA2R). In severe cases or when spontaneous remission is not achiev
Autor:
Manuel Alfredo Podestà, Federica Mescia, Anna Ricchiuto, Rona Smith, Martina Tedesco, Matthias Arnaldo Cassia, Julia Holle, Renato Alberto Sinico, Annette Bruchfeld, Iva Gunnarsson, Sophie Ohlsson, Bo Baslund, Zdenka Hruskova, Vladimir Tesar, Gianmarco Sabiu, Maurizio Gallieni, Maria C Cid, Augusto Vaglio, Lorraine Harper, Mario Cozzolino, Francesco Scolari, David Jayne, Federico Alberici
Objectives Rituximab has become the cornerstone of induction treatment in ANCA-associated vasculitis (AAV). B-cell depletion may increase the risk of hypogammaglobulinemia, potentially leading to severe infections. This study aims to assess factors a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea2fd32006df38d89af402340e6ba9d
https://hdl.handle.net/2434/950808
https://hdl.handle.net/2434/950808
Autor:
David Jayne, Alice Guerini, Andreas Kronbichler, Federico Alberici, Matija Crnogorac, Annette Bruchfeld, Federica Mescia, Anna Ricchiuto, Iva Gunnarsson, Rosanna Lacetera, Anna Juto, Mark A. Little, Renato Alberto Sinico, Martina Uzzo, Vladimir Stoyanov, Francesco Scolari, Stefania Affatato, Giorgio Trivioli, Gaetano La Manna, Mario Cozzolino, Jennifer Scott, Krešimir Galešić, Stephen P. McAdoo, Jennifer O'Brien, Federico Pieruzzi, Marco Allinovi
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Renal involvement in ANCA-associated vasculitis (AAV) impacts significantly on patients’ prognosis. The role of different induction regimens on remission rates and long-term renal outcomes according to renal histological charact
Autor:
Laila-Yasmin Mani, Angelo Ferrantelli, Francesco Scolari, Marco Quaglia, Nadia Dallera, Antonello Pani, Marisa Santostefano, Domenico Santoro, Riccardo Magistroni, Federico Alberici, Giuliano Boscutti, Gian Marco Ghiggeri, Elisa Delbarba, Pietro Ravani, Claudio Ponticelli, Sandro Feriozzi, Loreto Gesualdo, Carmelita Marcantoni, Patrizia Passerini
Publikováno v:
J Am Soc Nephrol
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for membranous nephropathy. Compared with this regimen, rituximab therapy might have a more favorable safety profile, but a head-to-head comparison is lacking. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a252a20595580d92523e875fc1d6fb
http://hdl.handle.net/11570/3217250
http://hdl.handle.net/11570/3217250
Autor:
Elena Oliva, Rosaria Santi, Lucio Manenti, Augusto Vaglio, Simeone Andrulli, Bruno Tumiati, Maria Letizia Urban, Alberto Pesci, Chiara Grasselli, Federica Maritati, Francesca Santarsia, Laura Pavone, Carlo Buzio, Alessandra Palmisano, Federico Alberici
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185880 (2017)
PLoS ONE
PLoS ONE
Objectives The treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is based on remission-induction and remission-maintenance. Methotrexate is a widely used immunosuppressant but only a few studies explored its role fo
Autor:
Nadeem Hasan, Julia U Holle, David Jayne, Augusto Vaglio, Bo Baslund, Federico Alberici, Mark A. Little, Raashid Luqmani, Kerstin Westman, Oliver Flossmann, Coen A. Stegeman, Philip Seo, Andrew Judge, Vladimir Tesar, Alessandra Palmisano, Denise Brown, Zdenka Hruskova, Ravi Suppiah, Chetan Mukhtyar, Peter A. Merkel
Publikováno v:
Annals of the Rheumatic Diseases, 70(1), 80-85. BMJ PUBLISHING GROUP
Objectives To compare the Vasculitis Damage Index (VDI) with the Combined Damage Assessment Index (CDA) as measures of damage from vasculitis.Methods A total of 283 patients with vasculitis from 11 European centres were evaluated in a cross-sectional
Autor:
Darren M. Roberts, Dinakantha S. Kumaratne, David Jayne, Stella Burns, Rachel B Jones, Federico Alberici, Rona M Smith
Publikováno v:
Journal of autoimmunity. 57
Rituximab is a B cell depleting monoclonal antibody used to treat lymphoma and autoimmune disease. Hypogammaglobulinemia has occurred after rituximab for lymphoma and rheumatoid arthritis but data are scarce for other autoimmune indications. This stu
Autor:
David Jayne, Federico Alberici
ANCA-associated vasculitis (AAV) is a subgrouping of autoimmune disorders characterized by a chronic relapsing course. Induction therapy is usually effective, but 70% of patients will relapse and 20% develop refractory disease. In the relapsing and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8e3fc05ce220aa5ffe1a9e718625fc
http://hdl.handle.net/11379/527323
http://hdl.handle.net/11379/527323
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis
Autor:
Julia U Holle, Zdenka Hruskova, Oliver Flossmann, Vladimir Tesar, David Jayne, Federico Alberici, Kerstin Westman, Mark A. Little, Ravi Suppiah, Alessandra Palmisano, R N Batra, Augusto Vaglio, Chetan Mukhtyar, Raashid Luqmani, Bo Baslund, Coen A. Stegeman, Andrew Judge, Denise Brown
Publikováno v:
Rheumatology, 50(5), 899-905. Oxford University Press
OBJECTIVE: Assessment of disease activity in vasculitis can be achieved using the BVAS, a clinical checklist of relevant symptoms, signs and features of active disease. The aim of this study was to revalidate the BVAS version 3 (BVAS v. 3) in a cohor
Autor:
Federica Maritati, Augusto Vaglio, Federico Alberici, Elena Oliva, Carlo Buzio, Maria Letizia Urban
Publikováno v:
La Presse Médicale. 42:696-697